Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 79 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

14%

11 trials in Phase 3/4

Results Transparency

1 of 11 completed trials have results

Key Signals

25 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

25(46.3%)

N/A

13(24.1%)

Phase 3

8(14.8%)

Phase 1

5(9.3%)

Phase 4

3(5.6%)

54Total

Phase 2(25)

N/A(13)

Phase 3(8)

Phase 1(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (79)

Showing 20 of 79 trials

NCT06146946Not ApplicableRecruiting

Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)

Role: collaborator

NCT07743749Recruiting

An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors

Role: collaborator

NCT03012971Not ApplicableActive Not Recruiting

Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery

Role: collaborator

NCT07687225Not ApplicableNot Yet Recruiting

Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases

Role: collaborator

NCT07682376Phase 2Active Not Recruiting

Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Role: collaborator

NCT04793672Completed

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Role: collaborator

NCT07646145Phase 2Recruiting

Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer

Role: lead

NCT07306390Not Yet Recruiting

Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)

Role: collaborator

NCT07162506Phase 2Recruiting

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Role: collaborator

NCT07038629Phase 2Recruiting

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Role: collaborator

NCT05788029Not ApplicableEnrolling By Invitation

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Role: collaborator

NCT07586813Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Role: collaborator

NCT07586826Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Role: collaborator

NCT07569055Recruiting

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT07489339Not ApplicableCompleted

MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy

Role: lead

NCT07498972Not ApplicableCompleted

Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer

Role: lead

NCT07490639Not ApplicableCompleted

Family-Supported Palliative Care in Advanced Lung Cancer

Role: lead

NCT07486648Phase 1Not Yet Recruiting

Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib

Role: lead

NCT07370116Phase 2Not Yet Recruiting

Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy

Role: collaborator

NCT07454941Enrolling By Invitation

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Role: collaborator